|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.28 SEK | -0.34% |
|
+9.00% | +76.64% |
| 06-27 | Hansa Biopharma AB Announces Board Appointments | CI |
| 05-31 | Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial | MT |
Hansa Biopharma AB (publ) at its Annual General Meeting held on June 27, 2024, resolved election of Florian Reinaud and Jonas Wikström, as members of the Board of Directors for the period until the end of the next Annual General Meeting.
| 1st Jan change | Capi. | |
|---|---|---|
| +76.64% | 296M | |
| +19.41% | 45.51B | |
| +38.65% | 38.13B | |
| -8.62% | 38.52B | |
| +26.95% | 30.74B | |
| -13.50% | 26.03B | |
| +10.74% | 25.92B | |
| +44.87% | 14.13B | |
| +34.36% | 12.73B | |
| -7.14% | 11.29B |
HANSA BIOPHARMA AB 
